首页 | 本学科首页   官方微博 | 高级检索  
     


Comparison of the NCCN-IPI,the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas
Authors:Fredrik Ellin  Matthew J. Maurer  Line Srour  Umar Farooq  Mats Jerkeman  Joseph M. Connors  Karin E. Smedby  N. Nora Bennani  Stephen M. Ansell  Graham W. Slack  James R. Cerhan  Thomas Relander  Andrew L. Feldman  Kerry J. Savage
Affiliation:1. Department of Clinical Sciences Lund, Lund University, Lund, Sweden;2. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA;3. Cancer Centre for Lymphoid Cancer and University of British Columbia, Vancouver, BC, Canada

Division of Hematology and Oncology, CISSS-MC - Charles LeMoyne Hospital, Greenfield Park, QC, Canada;4. Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa, Iowa City, IA, USA;5. Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada;6. Division of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden;7. Division of Hematology, Mayo Clinic, Rochester, MN, USA;8. Department of Pathology and Laboratory Medicine, BC Cancer, Vancouver, BC, Canada;9. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

Abstract:
Keywords:peripheral T-cell lymphoma  prognostic factors  NCCN-IPI  PIT  IPI
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号